TRPV1 and Hyperoxaluria: Blockade of TRPV1 mitigates the detrimental effect of inflammation-induced tubular damage in both in vitro and in vivo models of hyperoxaluria, indicating a potential role of TRPV1 antagonism in the treatment of oxalate nephropathy.